Recent update from the regulatory landscape in clinical data management
Date: September 24, 2026
On 22 September, MHRA published a new set of inspection dossier documents specifically for computerized systems in support of clinical trials.
You can download the new templates on the MHRA GCP hub: https://www.gov.uk/guidance/clinical-trials-for-medicines-good-clinical-practice-inspections
Scroll down to the Pre-inspection documentation tab to find the:
- GCP inspection dossier template – Computerised Systems
- GCP inspection dossier clinical trial spreadsheet – Computerised Systems
- GGP inspection dossier checklist – Computerised Systems.
MHRA last updated the dossier documents in Dec 2025 to include a new section 13 on Artificial Intelligence and Machine Learning (AI/ML). The new Computerized Systems documents continue the focus on managing and documenting usage of AI/ML and traditional computerized systems.
An initial review of the new documents underscores the MHRA emphasis on risk management throughout the entire software development lifecycle including validation status and change control.
For example in the inspection dossier spreadsheet, the tab S1 Item 4- clinical trials includes questions such as:
- Number of substantial protocol amendments/modifications
- Number of change controls
- How many of these change controls related to a protocol amendment/modification
The ACDM DMEG for Regulatory considerations recommends that data managers review the new documents to ensure that their validation and documentation efforts will support MHRA inspections.
Explore More News

Welcome Algorics as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Algorics as a . . .
Read More

Consultation response on legislative proposals for clinical trials
The MHRA have published the public consultation response to the proposals to reform the . . .
Read More

New MHRA Guidance
The MHRA have published new guidance on ‘Software and Artificial Intelligence (AI) as a . . .
Read More

FDA Guidance for Industry
The FDA has issued a final guidance to provide information on risk-based approaches to . . .
Read More

Guideline on computerised systems and electronic data in clinical trials
The European Medicines Agency (EMA) have published the new guidelines on computerised . . .
Read More

Welcome IROS – Insights Research Organization & Solutions as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome IROS – Insights . . .
Read More

Recommendation paper on decentralised elements in clinical trials
Following their meeting on 4 Oct, the EMA/HTAs and EC have published a recommendation . . .
Read More

Welcome George Clinical as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome George Clinical . . .
Read More

Welcome Clinion as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Clinion as a . . .
Read More

Welcome ClinoSol Research as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome ClinoSol . . .
Read More

CTU DMEG Update
The CTU DMEG has been actively discussing common problems that data managers face in . . .
Read More

ICH E8 (R1) General Considerations for Clinical Studies Impact on Data Management
The ACDM Regulatory Considerations have reviewed the Revision 1 to the ICH E8 Guidelines . . .
Read More